导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.08% | 120/1219 |
| 近一周 | -0.75% | 1331/1457 |
| 近一月 | -2.47% | 1371/1444 |
| 近一季 | -0.73% | 1185/1402 |
| 近半年 | 9.38% | 130/1318 |
| 近一年 | 12.87% | 125/1210 |
| 近两年 | 16.96% | 180/1014 |
| 近三年 | 10.75% | 447/841 |
| 成立以来 | 66.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
3.14% 116/1314 |
2.87% 151/1383 |
10.81% 111/1469 |
- - |
| 2024 | 1.81% 966/1292 |
-1.54% 993/1173 |
-1.48% 1129/1208 |
1.89% 458/1251 |
3.01% 190/1292 |
| 2023 | -4.83% 894/1121 |
1.00% 664/995 |
-1.16% 861/1035 |
-2.58% 899/1075 |
-2.13% 932/1121 |
| 2022 | -7.28% 585/955 |
-7.27% 642/793 |
4.84% 108/850 |
-3.64% 653/895 |
-1.02% 449/955 |
| 2021 | 18.50% 64/782 |
-1.75% 589/692 |
5.71% 43/754 |
8.98% 28/825 |
4.69% 116/782 |
| 2020 | 12.88% 139/632 |
-1.35% 555/607 |
0.34% 400/665 |
7.65% 15/685 |
5.94% 51/708 |
| 2019 | 19.44% 57/548 |
14.14% 48/1682 |
-3.25% 1614/1824 |
2.17% 165/614 |
5.85% 45/630 |
| 2018 | -3.29% 334/500 |
- - |
- - |
- - |
-0.64% 1190/1543 |
| 2017 | 3.38% 158/499 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 华富安享债券A VS. () |